More Questions Than Answers

There are two things that puzzle me about the insistence that all Americans be vaccinated against Covid-19. The first is the lack of emphasis on the methods of treatment that have proven to be successful–Hydroxychloroquine and Azithromycin, Ivermectin, Resveratrol, etc. Various combinations of these substances have been proven effective in treating even severe Covid-19 cases. The second thing that puzzles me is the total ignoring of the concept of immunity due to having recovered from the disease.

Yesterday The Epoch Times posted an article about a new study of Covid-19 cases and those who have recovered from the disease.

The article reports:

People who have recovered from COVID-19 retain broad and effective longer-term immunity to the disease, according to a new study.

Findings of the study, which is the most comprehensive of its kind so far, have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.

For the longitudinal study in Cell Reports Medicine, researchers looked at 254 patients with mostly mild to moderate symptoms of SARS-CoV-2 infection over a period of more than eight months (250 days) and found that their immune response to the virus remained durable and strong.

The findings are reassuring, especially given early reports during the pandemic that protective neutralizing antibodies didn’t last in COVID-19 patients, said Rafi Ahmed, director of the Emory University Vaccine Center and a lead author of the paper.

“The study serves as a framework to define and predict long-lived immunity to SARS-CoV-2 after natural infection. We also saw indications in this phase that natural immunity could continue to persist,” Ahmed said.

The research team will continue to evaluate this cohort over the next few years.

The article notes:

In following the patients for months, researchers got a more nuanced view of how the immune system responds to COVID-19 infection. The picture that emerges indicates that the body’s defense shield not only produces an array of neutralizing antibodies but activates certain T and B cells to establish immune memory, offering more sustained defenses against reinfection.

…Ahmed said investigators were surprised to see that convalescent participants also displayed increased immunity against common human coronaviruses as well as SARS-CoV-1, a close relative of the current coronavirus. The study suggests that patients who survived COVID-19 are likely to also possess protective immunity even against some SARS-CoV-2 variants.

“Vaccines that target other parts of the virus rather than just the spike protein may be more helpful in containing infection as SARS-CoV-2 variants overtake the prevailing strains,” Ahmed said. “This could pave the way for us to design vaccines that address multiple coronaviruses.”

The researchers said the study more comprehensively identifies the adaptive immune components leading to recovery, and that it will serve as a benchmark for immune memory induced by SARS-CoV-2 vaccines.

This is good news.

Don’t Look For This Information In The Mainstream Media

The Epoch Times posted an article today with the following headline, “Most Recovered COVID-19 Patients Have Broad, Robust Immunity That Likely Provides Some Protection Against Variants: Study.” Then why are people who have recovered from the virus being encouraged to get the vaccine?

The article reports:

Most people who have recovered from COVID-19, even with mild illness, retain a broad and durable immunity to the disease, including some degree of protection against its variants, according to an Emory University study published in the journal, Cell Reports Medicine.

The longitudinal study, the most comprehensive of its kind to date, involved 254 COVID-19 patients, between the ages of 18 to 82 years, who provided blood samples at various points for a period of over eight months beginning in April 2020. About 71 percent of the patients had mild disease, 24 percent experienced moderate illness, and five percent had severe disease.

The researchers found that most of the patients who recovered mounted a strong and wide-ranging immune response to the CCP (Chinese Communist Party) virus for up to 250 days.

“We saw that antibody responses, especially IgG antibodies, were not only durable in the vast majority of patients but decayed at a slower rate than previously estimated, which suggests that patients are generating longer-lived plasma cells that can neutralize the SARS-CoV-2 spike protein,” Rafi Ahmed, director at Emory Vaccine Center and lead author told Emory News Center on July 22.

The article concludes:

The authors also found that COVID-19 recovered patients displayed stable antibody responses to the other human coronaviruses that cause the common cold, the Middle East Respiratory Syndrome, or the severe acute respiratory syndrome (SARS-CoV).

“These data are most consistent with the generation of long-lived plasma cells and refute the current notion that these antibody responses to human coronaviruses are short lived,” the researchers said. “Moreover, the COVID-19 patients mounted increased IgG antibody responses to SARS-CoV-1, a related pathogen that none likely had experienced previous exposure to.”

The researchers will continue to follow the cohort for several years, with the last sample collection of the participants set for February 2023. Doing so allows the researchers to gather more data to “define the progression to long-lived immunity” to the CCP virus after natural infection.

The findings add to the growing body of research that indicates that recovered COVID-19 patients develop long-lasting immunity.

A limitation of the study is that it didn’t include more severe COVID-19 patients and those who are asymptomatic. However, the authors noted that “mild-moderate illness accounts for [more than] 80 percent of COVID-19 cases, highlighting the relevance of our findings over time.”

The authors said that the study’s findings will “also serve as a benchmark for immune memory induced in humans by SARS-CoV-2 vaccines.”

If my having had COVID-19 means that I will be less likely to get a cold this winter, then it was worth it! Seriously, COVID-19 is serious and not to be taken lightly, but anyone who has not yet taken the vaccine needs to weigh very carefully the risk/benefit ratio. Getting COVID-19 was not a pleasant experience, and I am grateful that my case did not include serious complications, but one problem with this virus is that no one can predict how it will impact a particular person. I am in a high-risk group, yet I did not experience severe symptoms. I strongly encourage anyone who has not yet taken the vaccine to do their own research to determine what is best for them as an individual.

Strange Things Happened At The End Of The Obama Administration

There were a number of odd things that happened toward the end of the Obama administration. There was the Susan Rice memo about the January 5, 2017, meeting (story here), the large number of unmasking requests (story here), but there is another odd thing that has just been discovered.

On Saturday The Conservative Treehouse posted an article about the ban on gain-of-function research.

The article reports:

…Eleven Days before leaving office President Obama’s administration re-authorized funding for the creation of biological weapons using SARS viruses. However, essentially this re-authorization was only kickstarting funding within the U.S. because the funding of weaponization of SARS-CoV-2 never actually stopped in 2014. The media reporting on this is misleading, if not downright false.

The article continues:

The article includes a summary of events:

SUMMARY: President Obama (not Trump) started the reauthorization of SARS-CoV-2 Virus experimentation in 2017.  The funding of the Wuhan Lab for the creation of SARS-CoV-2 was originated during the Obama administration and continued during the Trump administration.  The scientific community, the Obama White House and National Security Team, and the Pentagon knew the dangers of funding the weaponization of a biological weapon from SARS.  The COVID-19 pandemic was an outcome of these originating decisions.

…. and yes, there are political and ideological benefits from the perspective of Obama’s ideological group for unleashing the SARS-CoV-2 Pandemic as an opportunistic “crisis” to create totalitarian government solutions regardless of who was in office.  However, the timing of the subsequent biological release is very suspicious in relation to the 2020 presidential election and the downstream benefits of manipulating the election via mail-in ballots.

Perhaps not a smoking gun of intent, but definitely bloody footprints walking out the door – in Obama’s size.

Something to consider as you listen to the news.